Literature DB >> 25576392

The challenges of developing effective anti-inflammatory agents in cystic fibrosis.

Scott D Sagel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25576392     DOI： 10.1016/j.jcf.2014.12.004

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN： 1569-1993            Impact factor:   5.482


× No keyword cloud information.
  2 in total

1.  Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa.

Authors:  Paul M Beringer; Timothy J Bensman; Henry Ho; Melissa Agnello; Nicole Denovel; Albert Nguyen; Annie Wong-Beringer; Rosemary She; Dat Q Tran; Samuel M Moskowitz; Michael E Selsted
Journal:  J Antimicrob Chemother       Date:  2015-10-03       Impact factor: 5.790

Review 2.  New and Emerging Treatments for Cystic Fibrosis.

Authors:  Peter J Barry; Andrew M Jones
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.